Myomo (MYO) Notes Payables (2016 - 2025)
Myomo's (MYO) quarterly Notes Payables came in at $999418.0 in Q4 2025, up 1180.57% on a QoQ basis from $78045.0 in Q3 2020.
Myomo (MYO) Notes Payables (2016 - 2025) Analysis & Trends
Myomo (MYO) has 6 years of Notes Payables data on file, last reported at $999418.0 in Q4 2025.
- Quarterly Notes Payables changed N/A year-over-year to $999418.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $999418.0 (changed N/A YoY) and the FY2025 annual result came in at $999418.0, changed N/A from the prior year.
- Notes Payables grew to $999418.0 in Q4 2025, from $78045.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $999418.0 in Q4 2025 to a low of $999418.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 999,418.00 |
| Sep 30, 2020 | 78,045.00 |
| Jun 30, 2020 | 996,841.00 |
| Mar 31, 2020 | 40,605.00 |
| Dec 31, 2019 | 378,239.00 |
| Sep 30, 2019 | 43,942.00 |
| Jun 30, 2019 | 58,477.00 |
| Mar 31, 2019 | 157,927.00 |
| Dec 31, 2018 | 3,661.00 |
| Sep 30, 2018 | 8,652.00 |
| Jun 30, 2018 | 21,962.00 |
| Mar 31, 2018 | 24,623.00 |
| Dec 31, 2017 | 39,930.00 |
| Sep 30, 2017 | 92,359.00 |
| Dec 31, 2016 | 876,458.00 |